Works matching IS 01145916 AND DT 2020 AND VI 43 AND IP 3

Results: 10

Spontaneous Fluctuations in Liver Biochemistries in Patients with Compensated NASH Cirrhosis: Implications for Drug Hepatotoxicity Monitoring.

Published in:

2020

By:

Shamseddeen, Hani;
Vilar-Gomez, Eduardo;
Chalasani, Naga;
Myers, Robert P.;
Subramanian, G. Mani;
Shlevin, Harold H.;
Allgood, Adam E.;
Orman, Eric S.

Publication type:

journal article

Brand-Specific Enhanced Safety Surveillance of GSK's Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain for the 2018/2019 Season.

Published in:

Drug Safety, 2020, v. 43, n. 3, p. 265, doi. 10.1007/s40264-019-00893-4

By:

Dos Santos, Gael;
Nguyen, Bach-Yen;
Damaso, Silvia;
Godderis, Lode;
Martínez-Gómez, Xavier;
Eckermann, Tamara;
Loos, Hugo;
Salamanca de la Cueva, Ignacio;
Shende, Vishvesh;
Schmidt, Alexander C.;
Yeakey, Anne

Publication type:

Article

Follow-Up on the Use of Machine Learning in Clinical Quality Assurance: Can We Detect Adverse Event Under-Reporting in Oncology Trials?

Published in:

2020

By:

Ménard, Timothé;
Koneswarakantha, Björn;
Rolo, Donato;
Barmaz, Yves;
Popko, Leszek;
Bowling, Rich

Publication type:

Letter

The UK BIO-TRAC Study: A Cross-Sectional Study of Product and Batch Traceability for Biologics in Clinical Practice and Electronic Adverse Drug Reaction Reporting in the UK.

Published in:

Drug Safety, 2020, v. 43, n. 3, p. 255, doi. 10.1007/s40264-019-00891-6

By:

Klein, Kevin;
Hazell, Lorna;
Stolk, Pieter;
Shakir, Saad

Publication type:

Article

Contribution of Causality Assessment for an Automated Detection of Safety Signals: An Example Using the French Pharmacovigilance Database.

Published in:

Drug Safety, 2020, v. 43, n. 3, p. 243, doi. 10.1007/s40264-019-00887-2

By:

Berbain, Thomas;
Pariente, Antoine;
Miremont-Salamé, Ghada;
Grandvuillemin, Aurélie;
Micallef, Joelle;
Chouchana, Laurent;
Benkebil, Mehdi;
Théophile, Hélène

Publication type:

Article

Insight into the Severity of Adverse Drug Reactions as Experienced by Patients.

Published in:

2020

By:

Rolfes, Leàn;
Haaksman, Michelle;
van Hunsel, Florence;
van Puijenbroek, Eugène

Publication type:

Letter to the Editor

Drug-Induced Hypophosphatemia: Current Insights.

Published in:

Drug Safety, 2020, v. 43, n. 3, p. 197, doi. 10.1007/s40264-019-00888-1

By:

Megapanou, Efstathia;
Florentin, Matilda;
Milionis, Haralampos;
Elisaf, Moses;
Liamis, George

Publication type:

Article

Cardiac Safety of the Trastuzumab Biosimilar ABP 980 in Women with HER2-Positive Early Breast Cancer in the Randomized, Double-Blind, Active-Controlled LILAC Study.

Published in:

Drug Safety, 2020, v. 43, n. 3, p. 233, doi. 10.1007/s40264-019-00886-3

By:

Kolberg, Hans-Christian;
Colleoni, Marco;
Demetriou, Georgia Savva;
Santi, Patricia;
Tesch, Hans;
Fujiwara, Yasuhiro;
Tomasevic, Zorica;
Hanes, Vladimir

Publication type:

Article

Fatal Toxicity Indices for Medicine-Related Deaths in New Zealand, 2008–2013.

Published in:

Drug Safety, 2020, v. 43, n. 3, p. 223, doi. 10.1007/s40264-019-00885-4

By:

Fountain, John S.;
Tomlin, Andrew M.;
Reith, David M.;
Tilyard, Murray W.

Publication type:

Article

Prenatal Exposure to Macrolides and Risk of Congenital Malformations: A Meta-Analysis.

Published in:

Drug Safety, 2020, v. 43, n. 3, p. 211, doi. 10.1007/s40264-019-00884-5

By:

Mallah, Narmeen;
Tohidinik, Hamid Reza;
Etminan, Mahyar;
Figueiras, Adolfo;
Takkouche, Bahi

Publication type:

Article